Scotia Capital’s Xylem XYL Stock Holding History

Scotia Capital’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-40,000	Closed	-$1.31M	–	837
2015 Q3	$1.31M	Buy	+40,000	New	+$1.35M	0.03%	333

Other funds holding XYL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Scotia Capital's XYL Position: Q1 2026 in Review

Scotia Capital reduced its Xylem (XYL) stake by 6% in Q1 2026, selling an estimated $391K and leaving 46,731 shares worth $5.58M. The position accounts for 0.02% of the portfolio, ranked #287.

Scotia Capital first reported a position in XYL in Q3 2017 and has held it in 35 quarters since. The position peaked at $8.03M in Q1 2019. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

Scotia Capital held 46,731 shares of Xylem worth $5.58M as of Q1 2026.
Scotia Capital sold 2,982 Xylem shares in Q1 2026, an estimated $391K.
Xylem made up 0.02% of Scotia Capital's portfolio in Q1 2026, its #287 holding.
Scotia Capital first reported a position in Xylem in Q3 2017 and has held it in 35 quarters since.
Scotia Capital's Xylem position peaked at $8.03M in Q1 2019.
1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.